Background/Aims: Periodontitis with bone resorption is caused by inflammatory reactions to bacterial infection. We recently reported that electromagnetic wave irradiation (EMWI) has bactericidal effects. However, the effects of EMWI on periodontal tissues remain unclear. This study was aimed to investigate the effects of EMWI on osteoblasts. Methods: Osteoblastic cells MC3T3-E1 were treated with EMWI (500-1,000 kHz, 5 times, 1 sec/time). Cell growth and cytotoxicity were determined by cell proliferation assays and measurement of lactate dehydrogenase release, respectively. Gene expression and protein production of growth factors were analyzed using real-time PCR and ELISA, respectively. EMWI-activated cellular signal transduction pathways were investigated by immunoblotting and blocking assay with specific inhibitors. Results: Osteoblasts proliferation was significantly enhanced 3 days after EMWI and no cytotoxicity was observed. EMWI up-regulated various growth factors, such as vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF). EMWI induced ERK1/2, p38 MAPK and SAPK/JNK phosphorylation within 5 min, and the production of PDGF-ΑΑ and VEGF was partially reduced by MAPK-specific inhibitor. Conclusion: These findings demonstrated that EMWI increases osteoblastic cell activity and the expression of growth factors via ERK1/2 and p38 MAPK pathways and suggested that EMWI may be beneficial to bone tissue repair such as periodontitis.
Introduction
Periodontal diseases are highly prevalent and affect up to 90% of the worldwide population [1] . In addition to their high prevalence, these diseases are associated with serious public concerns, because periodontal diseases have been linked with various systemic diseases including cardiovascular disease, stroke, pulmonary disease, diabetes and adverse pregnancy outcomes. Periapical and marginal periodontitis are inflammatory disorders of peri-radicular and periodontal tissues caused by persistent microbial biofilms formed in the root canal system and periodontal pocket, respectively, which lead to destruction of supporting tissues of the tooth and finally to tooth loss [2] [3] [4] [5] [6] . Therefore, complete removal of bacteria and all causal agents within the root canal system and periodontal pocket by debridement is important for the prevention and treatment for periapical and marginal periodontitis. Another important point in the treatment of periodontitis is to promote wound healing of bony defects and surrounding tissues and to increase new bone formation as part of periodontal regenerative therapy.
Non-surgical treatment of periapical and marginal periodontitis has traditionally been accompanied with hand instruments, ultrasonic devices or local medications to remove bacterial deposits and infected tissues and to inactivate pathogenic bacteria. However, no consensus has been reached on whether ultrasonic treatment and mechanical removal with hand instruments can eliminate all pathogens present in infected sites [7] . Recently, laser therapy, such as with high-level erbium:yttrium-aluminium-garnet (Er:YAG) and neodymium:yttrium-aluminium-garnet (Nd:YAG) lasers, has been introduced in periodontal therapy, because dental lasers display several advantages that may be valuable in managing periodontal disease in addition to their anti-inflammatory effects [8] [9] [10] [11] [12] [13] [14] [15] . Previous studies have reported that Er:YAG laser irradiation has beneficial effects, including calculus removal, high bactericidal effect, and potential biostimulation [16] [17] [18] [19] [20] [21] and lower pulse energy Nd:YAG laser irradiation resulted in effective in eradication of both aerobic and anaerobic microorganisms as well as in neutralizing pro-inflammatory molecules such as lipopolysaccharide [22] [23] [24] . In recent years, in vitro and in vivo studies have reported that photodynamic therapy, combining low-energy laser light with photosensitizing compounds that bind to target cells, is useful for eradicating bacteria from periodontal pockets [23, [25] [26] [27] . However, the antimicrobial effects of laser irradiation are inversely proportional to the square of the distance from the light source to the target area. Several major problems have been pointed out with regard to laser irradiation. Laser light only travels in a straight line and does not reach the apical root portion through the curved root canal. It is also impossible to insert the light source tip near the apical root portion because of the narrow, curved root canal. Therefore, it remains necessary to improve the sharpness and material of laser tips for application in complex regions. So far, laser irradiation therapy for periapical and marginal periodontitis still has clinical limitations.
Recently, we reported that electromagnetic wave irradiation (EMWI) has inactivation and bactericidal activities against oral pathogens and suggested that EMWI has several advantages, such as rapid heating, pathogen destruction and inactivation, ease of control and compactness, over previously developed treatments. As such, EMWI may be applicable for medical disinfection and sterilization, such as in refractory periapical periodontitis [28] . In addition, using a thin, flexible instrument (K-file No. 10), which has suitable mechanical strength compared with smaller files (No. 6 and 8) as an active electrode, EMWI may be applicable to small, narrow, curved or complex morphological regions infected with bacteria. Therefore, EMWI has advantages over laser irradiation systems.
It has been reported that physical stresses, such as electrical stimulation and mechanical loading, promote osteogenesis and healing in bone fractures [29] . Since the discovery of the natural electrical properties of bone, the concept of electric current has been introduced as an important tool in bone remodeling, and various kinds of electrical stimulations have been investigated for their effects on bone regeneration [30] . Pulsed electromagnetic fields exert stimulating effects on the proliferation of osteoblasts and the production of cytokines, such as transforming growth factor (TGF)-β1 [31] [32] [33] . However, the effect of pulsed EMWI on osteoblasts has not yet been investigated. In this study, we investigated the activating effects of EMWI on osteoblastic cells to evaluate the potential application of EMWI to enhance the healing of periodontal lesions.
Materials and Methods

Osteoblastic cell line culture
The osteoblastic cell line MC3T3-E1 (European Collection of Cell Cultures, Salisbury, UK) established from mouse C57BL/6 calvaria was cultured in αMEM medium supplemented with 10% (vol/vol) fetal bovine serum (JRH Biosciences, Lenexa, KS, USA), 2 mM glutamine, 100 µg/ml streptomycin, and 100 units/ ml penicillin in 5% CO 2 at 37°C.
Electromagnetic wave (EMW) source and irradiation
Electromagnetic waves (EMWs) were generated using high-frequency therapy equipment (J. MORITA MFG. Corp., Kyoto, Japan) [28] . The frequency of EMWs from this treatment device was set to 500-1,000 kHz and 228 V, and tone-burst waves with a large crest factor were employed to efficiently generate arch discharges. An endodontic hand-operated instrument (K-file No. 10; MANI, Inc., Utsunomiya, Japan) as an active electrode tip was inserted 1 mm from the culture fluid surface and the current was passed intermittently for 1 sec/time at intervals of 2 seconds. The temperature of the cell culture medium during EMWI was monitored using a thermometer (CUSTUM CT-1300 Type K; CUSTUM, Tokyo, Japan).
Cell proliferation analysis MC3T3-E1 cells (8.0 × 10 3 cells/well, 0.5 ml/well) seeded in 48-well tissue culture plates were cultured for 1 day in 5% CO 2 at 37°C and treated with EMWI at 500, 750, and 1,000 kHz, 5 times (1 sec/ time). To determine cell proliferation activity, a TetraColor ONE Cell Proliferation Assay System (Seikagaku Biobusiness Co., Tokyo, Japan) was used, as described in the manufacturer's instructions. Briefly, 50 µl of TetraColor ONE was added to each well and the plates were incubated for 2 h. Tetrazolium monosodium salt present in TetraColor ONE was reduced by mitochondrial dehydrogenase in live cells, and the concentration of formazan produced was in proportion to the number of live cells. Proliferation, reflected by the amount of formazan, was then measured using a microplate reader (Bio-Rad Laboratories, Hercules, CA, USA) at 450 nm with a contrast wavelength of 655 nm. In addition to the assay based on mitochondrial activity, other cell proliferation assays, which do not rely metabolic status of the cell, were used. A Quantos Cell Proliferation Assay kit (Stratagene, La Jolla, CA, USA) was used to measure the amount of DNA in cells and a Bromodeoxyuridine (BrdU) Cell Proliferation Assay (EMD Millipore Co., San Diego, CA, USA) was used to measure BrdU incorporated into newly synthesized DNA strands of actively proliferation cells during the indicated 24-h culture, as described in the manufacturer's instructions.
Cell Cytotoxicity Assay
The effect of EMWI on cell cytotoxicity was determined using a lactate dehydrogenase (LDH) assay. MC3T3-E1 cells (1.8 × 10 4 cells/well, 0.5 ml/well) seeded in 48-well tissue culture plates were cultured for 1 day in 5% CO 2 at 37°C and treated by EMWI at 500 kHz, 5 times (1 sec/time). As a positive control, MC3T3-E1 cells were treated with 0.1% Triton X-100 and shaken gently for 10 min at room temperature. At 1, 3, or 5 days after EMWI, the levels of LDH in the recovered cell culture supernatants were determined using an LDH cytotoxicity assay kit (Cayman Chemical Co., Ann Arbor, MI, USA) in accordance with the manufacturer's instructions. Absorbance was measured at 490 nm using a microplate reader (Bio-Rad Laboratories).
Quantitative real-time PCR
Total RNA was isolated from EMWI-treated or non-irradiated control MC3T3-E1 cells (1.0 × 10 5 cells/ ml, 0.5 ml/well) using a NucleoSpin RNA kit (MACHEREY-NAGEL, Düren, Germany) in accordance with the manufacturer's instructions. The concentration of purified total RNA was measured using NanoDrop ND-1000 (Thermo Fisher Scientific, Waltham, MA, USA). Total RNA (400 ng) was used to synthesize (Table 1) .
ELISA for growth factors and osteopontin
The concentrations of vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF)−ΑΑ, PDGF−ΑΒ, PDGF−ΒΒ, osteopontin and TGF-β1 in cell culture supernatants were determined using a Quantikine ELISA kit (R&D Systems, Minneapolis, MN, USA) as described in the manufacturer's instructions.
Detection of phospho-specific MAPK activation
For analysis of the signal transduction pathway, EMWI-treated or non-irradiated control MC3T3-E1 cells (1.0 × 10 5 cells/ml, 0.5 ml/well) were washed once with cold phosphate-buffered saline followed by incubation on ice for 30 min with RIPA lysis buffer supplemented with protease and phosphatase inhibitors (Santa Cruz Biotechnology, Santa Cruz, CA, USA). After removal of debris by centrifugation, protein concentrations in the lysates were quantified using a Bicinchoninic Acid Protein Assay Kit (Sigma-Aldrich, St. Louis, MO, USA) using bovine serum albumin as a standard. Protein samples (8 µg) were separated on a 4-20% sodium dodecyl sulfate (SDS) polyacrylamide gel followed by electrotransfer onto a polyvinylidene difluoride membrane. Activation of extracellular signal-regulated kinase (ERK)1/2, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK)/ c-jun NH 2 -terminal kinase (JNK) was assessed using a Phospho-MAPK Family Rabbit mAb Sampler Kit and MAPK Family Antibody Sampler Kit (Cell Signaling Technology, Danvers, MA, USA) in accordance with the manufacturer's instructions. Actin levels were also assessed as an internal control using an anti-actin antibody (Sigma-Aldrich; 1:250 dilution). Protein bands were visualized by incubation with the horseradish peroxidase-conjugated secondary antibody (1:2,000 dilution) followed by detection using ECL Prime Western Blotting Detection Reagent (GE Healthcare, Buckinghamshire, UK). For evaluation of the activity of MAPK, the ratio of phosphorylated MAPK molecule and total MAPK molecule was analyzed by densitometric analysis with ImageJ 1.47 software (NIH, USA) after normalization with actin. 
Analysis of EMWI-treated cell signal transduction pathways
MC3T3-E1 cells (1.0 × 10 5 cells/ml, 0.5 ml/well) were seeded in 48-well tissue culture plates and were incubated for 1 day in 5% CO 2 at 37°C. For cell signaling analysis, cells were pretreated with the following specific inhibitors: PD98059 (for ERK1/2; 50 µM), SP600125 (for JNK; 20 µM), and SB203580 (for p38 MAPK; 20 µM), at 30 min prior to EMWI. Culture supernatants were collected at the indicated times and stored at -20°C until assayed.
Statistical analysis
Data are presented as mean ± SDs. The data corresponding to the EMWI-treated group and the respective control group were compared by unpaired Student's t test. The multifactorial one way analysis of variance (ANOVA) with Dunnett's post hoc test was used to assess differences between multiple sets of data. Differences were considered significant when the probability value was less than 5% (P<0.05).
Results
EMWI does not exert cytotoxicity on osteoblastic cells
First, we investigated the influence of EMWI on osteoblastic cells morphology. EMWI (500, 750 and 1,000 kHz, 5 times, 1 sec/time) did not cause any morphological change in the irradiated MC3T3-E1 cells over a period of 5 days (Fig. 1A at 500 kHz, data not shown at 750 and 1,000 kHz).
To confirm the absence of any cytotoxic effect of EMWI on osteoblastic cells, we next measured the level of LDH released from cells. As a positive control, MC3T3-E1 cells were treated with 0.1% Triton X-100 for 10 min. As shown in Fig. 1B , no cytotoxic effect of EMWI at 500 kHz, 5 times, 1 sec/time on MC3T3-E1 cells were observed.
To avoid tissue and cell damage by heating after EMWI, we further monitored the temperature of the culture medium during EMWI at 500 kHz. After 5 consecutive irradiations, the temperature of the culture medium increased to 40.0°C from 30.0°C before irradiation (Fig. 2) . The temperature of the culture medium increased with the number of irradiations at the rate of approximately 2.0°C per irradiation. As the irradiation current was passed intermittently for only 1 sec/time, the temperature decreased gradually after irradiation finished. These results indicated that EMWI does not damage osteoblastic cells morphologically, and suggested that heating by EMWI had little effect on osteoblastic cells. 2 . EMWI produces only a small change in the temperature of the culture medium. The temperature of the cell culture medium during EMWI at 500 kHz (1 sec/time) was monitored using a thermometer. Values represent the means ± SDs from representative of two independent experiments and each experiment was performed in quadruplicate. 4 . EMWI increases total RNA in osteoblastic cells. MC3T3-E1 cells were treated with EMWI at 500 kHz (5 times, 1 sec/time). Total RNA was isolated from EMWI-treated or non-irradiated MC3T3-E1 cells (3.0 × 10 4 cells/well) using a NucleoSpin RNA kit. The concentration of purified total RNA was measured using NanoDrop ND-1000. Values represent the means ± SDs from representative of four independent experiments and each experiment was performed in quadruplicate. *P<0.01 versus nonirradiated controls. A transient increase in temperature by EMWI does not affect the production of VEGF and osteopontin in osteoblastic cells. ELISA analysis of VEGF and osteopontin in non-irradiated control, pre-warmed medium-treated (40°C, 30 sec) and EMWI-treated (at 500 kHz, 5 times, 1 sec/time) MC3T3-E1 cells (1.0 × 10 5 cells/ml, 0.5 ml/well). Values represent the means ± SDs from representative of four independent experiments and each experiment was performed in quadruplicate. *P<0.01 versus non-irradiated controls.
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To further determine whether a transient increase in temperature by EMWI affect the production levels of growth factor and osteopontin, MC3T3-E1 cells was treated with prewarmed medium at 40°C for 30 sec and then replaced by the normal medium to culture for 24 hrs at 37°C (Fig. 7) . Pre-warmed medium treatment did not make MC3T3-E1 cells to increase VEGF and osteopontin productions, suggesting that a transient increase in temperature by EMWI does not affect the production of growth factors and osteopontin in MC3T3-E1 cells.
EMWI regulates the protein production of VEGF, PDGF-AA and osteopontin via MAPKs signaling pathways in osteoblastic cells
Reports have shown recently that low-level Er:YAG laser irradiation enhances osteoblast proliferation through activation of the ERK1/2 MAPK pathway [34] and the induction of FGF2 gene expression by mechanical stress is dependent on the ERK1/2 MAPK signal transduction pathway [35] . To elucidate the mechanism by which EMWI regulates the gene expression and protein production of various growth factors and osteopontin, we first tested the ability of EMWI to activate major cell signal transduction pathways, such as ERK1/2, p38 MAPK and SAPK/JNK. Immunoblotting analysis of ERK1/2, p38 MAPK and SAPK/JNK revealed that significant activation of all tested signal transduction molecules occurred within 5 min after EMWI and continued for 30 min (Fig. 8) .
We next examined the involvement of these major cell signal transduction pathways using specific inhibitors in the protein production of growth factors and osteopontin. MC3T3-E1 cells were pretreated with specific inhibitors PD98059 (ERK1/2 inhibitor), SB203580 (p38 MAPK inhibitor) or SP600125 (JNK inhibitor) at 30 min prior to EMWI at 500 kHz (5 times, 1 sec/time) (Fig. 9) . Inductions of VEGF and PDGF−ΑΑ were partially reduced by p38 MAPK inhibitor and ERK1/2 inhibitor, respectively. Moreover, induction of osteopontin was partially reduced by all tested inhibitors and strongly decreased to almost baseline levels by ERK1/2 inhibitor. 
Discussion
Recently, we demonstrated that the bactericidal effect of EMWI on selected oral pathogens [28] . A substantial number of preliminary in vitro, in vivo animal and clinical studies have demonstrated that electric energy is an important tool for enhancing bone formation. For example, electric energy has been used clinically to treat fresh, delayed or nonunion fractures, osteotomies and spine fusions [30] . We tried to determine the potential ability of EMWI as regenerative therapy for bone involvement, such as periapical and marginal periodontitis. Therefore, the current study extends our knowledge on the activating effects of EMWI on MC3T3-E1 osteoblastic cells to evaluate the possible use of EMWI to enhance the healing of periodontal lesions. This study demonstrated that EMWI enhanced osteoblastic cell proliferation and induced the gene expression of growth factors, including TGF-β1, VEGF, FGF2 and PDGF, and the extracellular structural protein of bone, osteopontin.
To avoid tissue and cell damage by EMWI, we first verified that EMWI at 500 kHz (5 times, 1 sec/time) was not especially cytotoxic, and did not cause any morphological change in MC3T3-E1 cells over a period of 5 days (Fig. 1) . We further confirmed that the temperature increased to 40.0°C from 30.0°C before irradiation after 5 consecutive irradiations and then decreased gradually after stopping irradiation because the irradiation current was passed intermittently for only 1 sec/time (Fig. 2) . These results indicated that EMWI does not damage osteoblastic cells, suggesting that EMWI is safe to use for clinical applications.
EMWI at 500, 750 and 1,000 kHz (5 times, 1 sec/time) could also stimulate osteoblastic cell proliferation (Fig. 3) . This finding appears to be in agreement with previous studies using various laser systems, which have shown laser-induced osteoblastic cell proliferation [15, 34] . Interestingly, one previous study showed an association between mechanical stimulation by pulse irradiation and an increase in osteoblast activity [36] , and another Cellular Physiology and Biochemistry study reported that electrical stimulation using an electric field significantly increased cell proliferation of osteoblasts [33] . Therefore, pulsed EMWI used in this study may have the potential to activate osteoblasts in periodontal tissues surrounding a tooth and to promote wound healing and bone tissue regeneration.
Our results also showed that total RNA was significantly increased in MC3T3-E1 cells 1 day after EMWI irradiation (Fig. 4) . This result strongly suggests transcriptional activation by EMWI. Because growth factors are involved in regulating cell viability and extracellular matrix remodeling during healing processes, we focused on growth factors and osteopontin and determined their expression and production levels and the mechanisms induced by EMWI. Using quantitative real-time PCR and ELISA, the expression and production levels of growth factors (vegf, tgf-ß1, pdgfa, pdgfb, ctgf, and fgf2) and osteopontin in EMWI-treated cells were significantly increased on day 1 after irradiation and continuously up-regulated during 1-3 days and 5-7 days after irradiation, respectively (Fig. 5, 6 ). Moreover, a transient increase in temperature using pre-warmed medium did not affect the production of growth factor and osteopontin in MC3T3-E1 cells (Fig. 7) , suggesting that EMWI-mediated activation of osteoblastic cells is not derived from a transient increased temperature. These results suggested that the up-regulation of growth factors and osteopontin may play a crucial role in regulating the viability and activation of osteoblastic cells after EMWI.
Migration of bone-forming osteoblastic cells is also thought to be important in many pathologic processes and bone physiology, including bone remodeling and fracture repair. Many local growth factors, including VEGF, PDGF, TGF-β and FGF, can promote migration in a variety of cell types and have been proposed as therapeutic agents in wound healing and fracture [37, 38] . Moreover, most growth factors are potent stimulators of cell proliferation.
It has been considered that angiogenesis is a prerequisite for bone formation along with close cross-talk between osteoblasts and endothelial cells [39, 40] . VEGF secreted from osteoblasts functions as a paracrine factor for neovascularization and causes endothelial cells to proliferate and stimulate blood vessel formation in bone tissue [41, 42] . In accordance with our present results, it has been reported that a biphasic electrical current coupled with an electromagnetic field can stimulate cell proliferation and up-regulate VEGF expression in osteoblasts [30] .
The PDGF family consists of 5 different dimeric proteins built from four different peptide chains [43] . PDGF is a potent mitogen and chemo-attractant for multiple types of cells including osteoblasts and osteoprogenitor cells and responsible for stimulating angiogenesis, and it has been documented that PDGF stimulates the proliferation of stem cells as its important role in the biology of fracture healing [44] [45] [46] [47] [48] [49] . Our results suggest that PDGF−ΑΑ and PDGF−ΑΒ up-regulated by EMWI may act as the mitogen and chemoattractant for various cells, which are necessary for bone tissue regeneration.
Several members of the TGF-β superfamily, including TGF-β1, modulate osteoblast differentiation and mineralization. TGF-β can also induce the synthesis of bone matrix proteins in osteoblasts as well as most major extracellular matrix proteins [50] . Therefore, up-regulation of TGF-β1 in osteoblastic cells by EMWI may play an important role in the production of extracellular matrix proteins during wound healing.
FGFs are involved in diverse cellular processes including cell differentiation and cell survival [51] . In particular, FGF2 stimulates MC3T3-E1 cell proliferation and differentiation in vitro [52] . Recent studies have shown that the efficacy of a human recombinant FGF2 for periodontal tissue regeneration was evaluated in a multi-center clinical trial and an application of FGF2 increased the rate of bone formation in individuals with fractures [53] [54] [55] . An in vivo study has also shown that FGF2 accelerates angiogenesis in necrotic bone [56] . Therefore, FGF2 up-regulated in osteoblastic cells by EMWI may be one of the most promising factors as shown in a clinical trial and an in vivo study.
CTGF, a member of the CCN family of proteins, is a secreted, extracellular matrixassociated protein in a variety of tissues, including bone, and acts as an autocrine or paracrine regulator of various cellular functions, such as proliferation, migration, matrix production and differentiation, with its specific effects being target-cell dependent [57] .
Previous reports have demonstrated that CTGF is necessary for osteoblastogenesis and required for normal osteoblastic function, and addition or overexpression of CTGF promotes osteoblast differentiation and function in cells of an osteoblastic lineage [58] [59] [60] [61] . CTGF has also been implicated in more complex biological processes, including angiogenesis and fracture repair [62] [63] [64] . Considering our findings and previous studies, EMWI-up-regulated CTGF may play an important role in the osteogenic response and then lead to bone formation and remodeling.
Osteopontin is one of the extracellular matrix proteins synthesized by osteoblastic cells during bone development and a cytokine that has been suggested to act in a number of physiological and pathological events including bone remodeling [65] [66] [67] . Consistent with a previous report showing that Nd:YAG laser irradiation could stimulate osteoblastic cells to increase the expression of osteopontin [15] , EMWI could continuously up-regulate ospteopontin production for 7 days.
MAPKs are serine/threonine kinases that phosphorylate transcription factors and other downstream kinases, mediating cellular signal transduction from the cell surface to the nucleus, and are responsible for many biological activities and cellular processes, such as proliferation and differentiation [68] . Three distinct groups of MAPKs: ERK, SAPK/JNK and p38 MAPK, have been identified. In particular, it has been shown that MAPKs are differentially expressed in different cell types and strongly correlated with cell proliferation as a reaction to extracellular stimuli [69] . Furthermore, normal osteoblast-specific gene expression and differentiation in vitro require MAPKs [70, 71] . It is also well accepted that these MAPKs are activated by growth factors [69, 72, 73] . Our results demonstrated that EMWI strongly increased MAPK phosphorylation and activated the MAPK pathways compared with those of unirradiated control cells (Fig. 8) . Moreover, a p38 MAPK-specific inhibitor significantly inhibited VEGF production, and ERK-specific inhibitor strongly reduced the production of PDGF−ΑΑ and osteopontin. A JNK inhibitor could also inhibit osteopontin weakly. These findings indicated that the up-regulation of growth factors and osteopontin is mediated by these MAPKs pathways. A previous study also indicated a strong correlation between osteoblast proliferation using low-level Er:YAG laser irradiation and specific activation of MAPKs [34] . Therefore, EMWI-induced growth factors in osteoblasts may be able to activate the surrounding cells by autocrine and paracrine mechanisms and finally lead to bone tissue regeneration.
In conclusion, EMWI significantly induced osteoblast proliferation and up-regulated the transcriptional and protein levels of growth factors and osteopontin, indicating that EMWI can efficiently switch on some potential regulator of growth factors, which may be important for bone regeneration mediated by osteoblasts. This study is valuable in its assessment of EMWI using an in vitro model as a new type of electrical stimulation for osteogenesis and raises the possibility that EMWI could be a useful new method for promoting bone tissue regeneration, such as in periodontal tissues.
